首页> 美国卫生研究院文献>Internal Medicine >Pulmonary Tuberculosis Complicated with Severe Thrombocytopenia with Diffuse Alveolar Hemorrhaging during Anti-tuberculosis Chemotherapy: An Autopsy Report
【2h】

Pulmonary Tuberculosis Complicated with Severe Thrombocytopenia with Diffuse Alveolar Hemorrhaging during Anti-tuberculosis Chemotherapy: An Autopsy Report

机译:肺结核合并严重血小板减少症伴抗肺结核化疗期间弥漫性肺泡大出血:尸检报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Tuberculosis may be accompanied by various hematological abnormalities during treatment, and occasionally thrombocytopenia is also noted. Most cases of thrombocytopenia in tuberculosis are moderate, and there are few reports about thrombocytopenia with diffuse alveolar hemorrhaging (DAH) in pulmonary tuberculosis. We describe the case of an 82-year-old man with pulmonary tuberculosis and tuberculous pleurisy. He underwent anti-tuberculosis chemotherapy; during tuberculosis treatment, he experienced DAH due to fulminant thrombocytopenia. Thrombocytopenia is a common finding in patients with pulmonary tuberculosis, but the laboratory findings should be carefully evaluated. Thrombocytopenia during anti-tuberculosis chemotherapy can cause life-threatening DAH.
机译:结核病在治疗过程中可能伴有各种血液学异常,偶尔还会出现血小板减少症。结核病中的血小板减少症大多数病例是中度的,关于肺结核中的弥漫性肺泡出血(DAH)的血小板减少症的报道很少。我们描述了一个患有肺结核和结核性胸膜炎的82岁男子的病例。他接受了抗结核化疗。在结核病治疗期间,由于暴发性血小板减少症,他经历了DAH。血小板减少症是肺结核患者的常见发现,但应仔细评估实验室检查结果。抗结核化疗期间的血小板减少症可导致危及生命的DAH。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号